Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term adverse effects. Found 219 abstracts

no pagination
Little DJ, Kuban DA, Levy LB, Zagars GK, Pollack A. Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology. 2003 Oct;62(4):707-13.
Ma GX, Fleisher L. Awareness of cancer information among Asian Americans. J Community Health. 2003 Apr;28(2):115-30.
McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, Michielli RA, Shen FM, Evans AA, London WT, Buetow KH. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res. 2003 Aug;63(15):4594-601.
Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys. 2003 May;56(1):192-8.
Schnoll RA, Bradley P, Miller SM, Unger M, Babb J, Cornfeld M. Psychological issues related to the use of spiral CT for lung cancer early detection. Lung Cancer. 2003 Mar;39(3):315-25.
Schnoll RA, Bradley P, Miller SM, Unger M, Babb J, Cornfeld M. Psychological issues related to the use of spiral CT for lung cancer early detection. Lung Cancer. 2003 Mar;39(3):315-25.
von Mehren M, Adams GP, Weiner LM. Monoclonal antibody therapy for cancer. Annu Rev Med. 2003 Jan;54:343-69.
Badawi AF, Habib SL, Mohammed MA, Abadi AA, Michael MS. Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer. Cancer Invest. 2002 Jan;20(5-6):651-6.
Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002 Feb;29(1):2-17.
Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol. 2002 Jan;20(1):153-9.
Crotty S, Hix L, Sigal LJ, Andino R. Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection. J Gen Virol. 2002 Jul;83(Pt 7):1707-20.
Dell DD. Deep vein thrombosis in the patient with cancer. Clinical journal of oncology nursing. 2002 Jan;6(1):43-6.
Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England journal of medicine. 2002 Aug 15;347(7):472-80.
Djousse L, Dorgan JF, Zhang Y, Schatzkin A, Hood M, D'Agostino RB, Copenhafer DL, Kreger BE, Ellison RC. Alcohol consumption and risk of lung cancer: the Framingham Study. Journal of the National Cancer Institute. 2002 Dec 18;94(24):1877-82.
Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):369-76.
Hudes G, Haas N, Yeslow G, Gillon T, Gunnarsson PO, Ellman M, Nordle O, Eriksson B, Miller L, Cisar L, Kopreski M, Viaro D, Hartley-Asp B. Phase I clinical and pharmacologic trial of intravenous estramustine phosphate. J Clin Oncol. 2002 Feb 15;20(4):1115-27.
Langer CJ, Choy H, Glaspy JA, Colowick A. Standards of care for anemia management in oncology: focus on lung carcinoma. Cancer. 2002 Aug;95(3):613-23.
Langer CJ, Manola J, Bernardo P, Kugler JW, Bonomi P, Cella D, Johnson DH. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. Journal of the National Cancer Institute. 2002 Feb 06;94(3):173-81.
Marsh JC, Catalano P, Huang J, Graham DL, Cornfeld MJ, O'Dwyer PJ, Benson AB. Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer. Clin Colorectal Cancer. 2002 May;2(1):43-50.
Narod SA, Dube MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes WD, Warner E, Kim-Sing C, Olopade O, Tung N, Saal HM, Weitzel J, Merajver S, Gauthier-Villars M, Jernstrom H, Sun P, Brunet JS. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 2002 Dec 04;94(23):1773-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term adverse effects

adverse effects Human Male Female US Gov't Support-PHS Middle Age Aged Adult etiology Non-US Gov't Support drug therapy Lung Neoplasms Smoking genetics therapeutic use Risk Factors Treatment Outcome chemically induced complications 80 and over Aged Quality of Life pathology administration & dosage Time Factors psychology Adenocarcinoma therapy Prostatic Neoplasms Animal Risk Assessment epidemiology Liver Neoplasms Odds Ratio Smoking Cessation blood Questionnaires Drug Administration Schedule drug effects Case-Control Studies Survival Analysis Mass Screening Confidence Intervals pharmacology Inbred C57BL Mice metabolism Gastrointestinal Hemorrhage Animal Disease Models Messenger RNA Follow-Up Studies antagonists & inhibitors Health Behavior Attitude to Health Liver Spiral Computed Tomography Radiotherapy Dosage Transgenic Mice virology physiopathology Oral Administration statistics & numerical data Hepatocellular Carcinoma Cohort Studies Adolescent Severity of Illness Index analogs & derivatives Self Efficacy Knowledge Patient Compliance radiography Breast Neoplasms Antineoplastic Agents pharmacokinetics Intravenous Infusions Organ Specificity Antineoplastic Combined Chemotherapy Protocols mortality radiotherapy prevention & control Mice Neoplasms physiology Drug Dose-Response Relationship Health Surveys Conserved Sequence Experimental Liver Neoplasms Cocarcinogenesis Nonparametric Statistics Asbestos Tissue Culture Non-Small-Cell Lung Carcinoma Erythropoietin Paralysis Data Collection Aging use Piperazines Massachusetts Oral Poliovirus Vaccine Bladder Neoplasms injuries Rectum Incidence Cross-Sectional Studies Protein-Tyrosine Kinase Pain Dinoprostone Occupational Exposure Urothelium Thrombocytopenia Paclitaxel Tetracycline Spinal Cord Endothelial Growth Factors Heparin biosynthesis Three-Dimensional Imaging therapeutic adverse Amino Acid Sequence Isoenzymes Simian virus 40 methods Neoplastic Gene Expression Regulation effects Retrospective Studies Attitudes Knowledge-Practice Hemoglobins US Gov't Support-Non-PHS Viral RNA Blood Transfusion Neoplasm Drug Resistance Fluorouracil New Jersey Poliomyelitis radiation effects immunology Knockout Mice BRCA2 Genes Tumor Suppressor Genes Mesothelioma Platinum Compounds Polymerase Chain Reaction Case Report BRCA1 Genes diagnosis Hepatitis B Turkey Heterozygote Immunotoxins pathogenicity
Last updated on Friday, January 03, 2020